UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
evolocumab (251) 251
science & technology (149) 149
life sciences & biomedicine (148) 148
alirocumab (132) 132
humans (102) 102
hypercholesterolemia (78) 78
pcsk9 (68) 68
cholesterol (64) 64
pharmacology & pharmacy (63) 63
proprotein convertase 9 - antagonists & inhibitors (56) 56
cardiovascular system & cardiology (55) 55
statins (55) 55
anticholesteremic agents - therapeutic use (50) 50
antibodies, monoclonal - therapeutic use (47) 47
cholesterol, ldl - blood (47) 47
cardiac & cardiovascular systems (46) 46
cardiovascular disease (44) 44
familial hypercholesterolemia (44) 44
lipids (44) 44
low density lipoproteins (41) 41
monoclonal antibodies (40) 40
hypercholesterolemia - drug therapy (37) 37
treatment outcome (37) 37
cardiovascular diseases (36) 36
female (36) 36
pcsk9 inhibitors (34) 34
male (32) 32
middle aged (31) 31
risk factors (31) 31
atherosclerosis (30) 30
lipoproteins (30) 30
aged (28) 28
proprotein convertase subtilisin/kexin type 9 (27) 27
antibodies, monoclonal - adverse effects (26) 26
anticholesteremic agents - adverse effects (26) 26
low density lipoprotein (26) 26
cardiovascular diseases - prevention & control (25) 25
ldl-c (25) 25
proprotein convertase 9 - metabolism (24) 24
dyslipidemia (23) 23
animals (22) 22
care and treatment (22) 22
proprotein convertase 9 (22) 22
drug therapy (21) 21
patients (21) 21
clinical trials (20) 20
abridged index medicus (19) 19
hyperlipidemia (19) 19
hyperlipoproteinemia type ii - drug therapy (19) 19
ldl cholesterol (19) 19
low-density lipoprotein cholesterol (19) 19
peripheral vascular disease (19) 19
safety (19) 19
anticholesteremic agents - pharmacology (18) 18
cardiology (18) 18
hypercholesterolemia - blood (18) 18
review (18) 18
adult (17) 17
biomarkers - blood (17) 17
bococizumab (17) 17
cardiovascular (17) 17
ezetimibe (17) 17
antibodies, monoclonal - administration & dosage (16) 16
dyslipidemias - drug therapy (16) 16
kexin (16) 16
proprotein convertases - antagonists & inhibitors (16) 16
anticholesteremic agents (15) 15
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (15) 15
medical research (15) 15
subtilisin (15) 15
analysis (14) 14
medicine & public health (14) 14
medicine, general & internal (14) 14
proprotein convertase subtilisin (14) 14
serine proteinase inhibitors - therapeutic use (14) 14
statin intolerance (14) 14
antibodies, monoclonal - pharmacology (13) 13
cardiovascular risk (13) 13
general & internal medicine (13) 13
monoclonal antibody (13) 13
serine proteinase inhibitors - adverse effects (13) 13
antibodies, monoclonal, humanized - therapeutic use (12) 12
anticholesteremic agents - administration & dosage (12) 12
drug therapy, combination (12) 12
internal medicine (12) 12
lipoprotein a (12) 12
pcsk9 inhibition (12) 12
research (12) 12
stroke (12) 12
apolipoproteins (11) 11
biochemistry & molecular biology (11) 11
cholesterol, ldl - metabolism (11) 11
diabetes (11) 11
drug dosages (11) 11
lipoprotein (11) 11
medicine, experimental (11) 11
development and progression (10) 10
efficacy (10) 10
genetic aspects (10) 10
inclisiran (10) 10
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (232) 232
Spanish (12) 12
Chinese (6) 6
German (5) 5
Czech (4) 4
French (4) 4
Swedish (2) 2
Norwegian (1) 1
Polish (1) 1
Portuguese (1) 1
Russian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Current pharmaceutical design, ISSN 1381-6128, 2018, Volume 24, Issue 31, pp. 3647 - 3653
Background: Familial hypercholesterolemia (FH) is an inherited autosomal dominant disorder that is characterized by substantially increased Low-Density... 
PCSK9 inhibitors | alirocumab | Familial hypercholesterolaemia | safety | efficacy | evolocumab | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology
Journal Article
The New England journal of medicine, ISSN 1533-4406, 04/2015, Volume 372, Issue 16, pp. 1500 - 1509
Journal Article
Circulation (New York, N.Y.), ISSN 0009-7322, 01/2018, Volume 137, Issue 4, pp. 338 - 350
Journal Article
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 2014, Volume 63, Issue 23, pp. 2541 - 2548
Journal Article
Clínica e investigación en arteriosclerosis, ISSN 0214-9168, 05/2016, Volume 28, pp. 22 - 30
The achievement of low-density lipoprotein (LDL) therapeutic targets is especially difficult in some patients at high cardiovascular risk. These patients... 
PCSK9 inhibitors | LDL | Evolocumab | Alirocumab | Familial hypercholesterolemia | Myalgias | Statin intolerance
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 04/2014, Volume 63, Issue 13, pp. 1278 - 1288
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 04/2016, Volume 315, Issue 15, pp. 1580 - 1590
Journal Article
Journal Article
Journal of Pharmacology and Pharmacotherapeutics, ISSN 0976-500X, 10/2016, Volume 7, Issue 4, pp. 190 - 193
The treatment of hypercholesterolemia entered in a new phase of development with the introduction of proprotein convertase subtilisin/kexin type 9 (PCSK9)... 
proprotein convertase subtilisin/kexin type 9 | Alirocumab | dyslipidemia | evolocumab | Development and progression | Genetic aspects | Enzyme inhibitors | Dyslipidemias | Drug therapy | Patient outcomes | kexin type 9 | proprotein convertase subtilisin | Molecules of Millennium
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 06/2014, Volume 63, Issue 23, pp. 2531 - 2540
Journal Article